T Diary (this app) is an app that supports self-management such as recording the medication status and symptoms of patients taking Tagrisso®. By using this app, you can "visualize" your medication status and your daily condition, and it will help you to properly inform your healthcare professional about your progress and status at the time of medical examination.
[Users eligible for use]
This app is intended only for patients taking Tagrisso®. Please note.
[What you can do with T Diary]
● Medication and symptom recording
・ Record of medication
You can record the medication status of Tagrisso® with one tap. In addition, the medication record can be reviewed in tables, graphs, and calendars along with the symptom record, supporting the habituation of medication and self-management.
・ Record of symptoms
You can easily record symptoms that may occur to the patient, such as "shortness of breath," "diarrhea," and "pain." In addition, you can keep a record of the events of the day by registering photos and using the memo function.
● Looking back
You can look back on the contents recorded in the medication record and symptom record in the table, graph, and calendar. Reviewing the records will help you understand when symptoms are likely to occur and inform your healthcare professional about the course of treatment.
● Registration of emergency contact information
By registering the medical institution you are visiting as an emergency contact, we support you to contact quickly in an emergency.
● Useful information
You can view useful information (below) related to the treatment of lung cancer in texts and videos.
・ Explanation of Tagrisso® side effect management (main side effects, medication method)
・ Explanation of points in self-care for each affected area
● Notification of medication time
When you register your time to take Tagrisso®, you will be notified by notification.
● Notice of next consultation date
When you register your next visit, you will be notified in advance.
■ Target area
This app is intended for use by residents of Japan.
Information
[Providing company]
AstraZeneca Co., Ltd.
[Supervision]
National Cancer Center National Cancer Center
Dr. Yuichiro Oe, Deputy Director of Central Hospital and Dean of Respiratory Medicine
Pharmacy Department Reiko Makihara
[Operating company]
Welby Co., Ltd. https://www.welby.jp
[Customer support]
Click here if you have any questions about how to download or how to use the app.
0120-095-655 (Weekdays 10: 00-17: 30)
Email: support@welby.jp
[Users eligible for use]
This app is intended only for patients taking Tagrisso®. Please note.
[What you can do with T Diary]
● Medication and symptom recording
・ Record of medication
You can record the medication status of Tagrisso® with one tap. In addition, the medication record can be reviewed in tables, graphs, and calendars along with the symptom record, supporting the habituation of medication and self-management.
・ Record of symptoms
You can easily record symptoms that may occur to the patient, such as "shortness of breath," "diarrhea," and "pain." In addition, you can keep a record of the events of the day by registering photos and using the memo function.
● Looking back
You can look back on the contents recorded in the medication record and symptom record in the table, graph, and calendar. Reviewing the records will help you understand when symptoms are likely to occur and inform your healthcare professional about the course of treatment.
● Registration of emergency contact information
By registering the medical institution you are visiting as an emergency contact, we support you to contact quickly in an emergency.
● Useful information
You can view useful information (below) related to the treatment of lung cancer in texts and videos.
・ Explanation of Tagrisso® side effect management (main side effects, medication method)
・ Explanation of points in self-care for each affected area
● Notification of medication time
When you register your time to take Tagrisso®, you will be notified by notification.
● Notice of next consultation date
When you register your next visit, you will be notified in advance.
■ Target area
This app is intended for use by residents of Japan.
Information
[Providing company]
AstraZeneca Co., Ltd.
[Supervision]
National Cancer Center National Cancer Center
Dr. Yuichiro Oe, Deputy Director of Central Hospital and Dean of Respiratory Medicine
Pharmacy Department Reiko Makihara
[Operating company]
Welby Co., Ltd. https://www.welby.jp
[Customer support]
Click here if you have any questions about how to download or how to use the app.
0120-095-655 (Weekdays 10: 00-17: 30)
Email: support@welby.jp
Show More
